Shapiro CL - Search Results

1

Shapiro CL, Yeap BY, Godleski J, Jochelson MS, Shipp MA, Skarin AT, Canellos GP. Shapiro CL, et al. Cancer. 1991 Aug 15;68(4):699-705. doi: 10.1002/1097-0142(19910815)68:4<699::aid-cncr2820680406>3.0.co;2-5. Cancer. 1991. PMID: 1713121

2

Hexamethylmelamine use in the treatment of metastatic breast cancer.

Henderson IC, Shapiro CL. Henderson IC, et al. Among authors: shapiro cl. Cancer Treat Rev. 1991 Mar;18 Suppl A:91-8. doi: 10.1016/0305-7372(91)90029-y. Cancer Treat Rev. 1991. PMID: 1904313 Review. No abstract available.

3

Late effects of adjuvant therapy for breast cancer.

Shapiro CL, Recht A. Shapiro CL, et al. J Natl Cancer Inst Monogr. 1994;(16):101-12. J Natl Cancer Inst Monogr. 1994. PMID: 7999452 Review. No abstract available.

4

Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.

Shapiro CL, Gelman RS, Hayes DF, Osteen R, Obando A, Canellos GP, Frei E 3rd, Henderson IC. Shapiro CL, et al. J Natl Cancer Inst. 1993 May 19;85(10):812-7. doi: 10.1093/jnci/85.10.812. J Natl Cancer Inst. 1993. PMID: 8487326 Clinical Trial.

5

A phase II trial of interferon-alpha and toremifene in advanced renal cell cancer patients.

Oh WK, Manola J, George DJ, Fierman A, Fontaine-Rothe P, Morrissey S, Prisby J, Kaufman DS, Shapiro CL, Kantoff PW, Smith MR. Oh WK, et al. Among authors: shapiro cl. Cancer Invest. 2002;20(2):186-91. doi: 10.1081/cnv-120001145. Cancer Invest. 2002. PMID: 11901538 Clinical Trial.

6

Treatment of metastatic breast cancer: present and future prospects.

Hayes DF, Henderson IC, Shapiro CL. Hayes DF, et al. Among authors: shapiro cl. Semin Oncol. 1995 Apr;22(2 Suppl 5):5-19; discussion 19-21. Semin Oncol. 1995. PMID: 7537913 Review.

7

Adjuvant therapy of breast cancer.

Shapiro CL, Henderson IC. Shapiro CL, et al. Hematol Oncol Clin North Am. 1994 Feb;8(1):213-31. Hematol Oncol Clin North Am. 1994. PMID: 8150781 Review.

8

Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.

Shapiro CL, Ayash L, Webb IJ, Gelman R, Keating J, Williams L, Demetri G, Clark P, Elias A, Duggan D, Hayes D, Hurd D, Henderson IC. Shapiro CL, et al. J Clin Oncol. 1997 Feb;15(2):674-83. doi: 10.1200/JCO.1997.15.2.674. J Clin Oncol. 1997. PMID: 9053493

9

The quality of care for treatment of early stage breast carcinoma: is it consistent with national guidelines?

Guadagnoli E, Shapiro CL, Weeks JC, Gurwitz JH, Borbas C, Soumerai SB. Guadagnoli E, et al. Among authors: shapiro cl. Cancer. 1998 Jul 15;83(2):302-9. Cancer. 1998. PMID: 9669813

10

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).

Costanza ME, Berry D, Henderson IC, Ratain MJ, Wu K, Shapiro C, Duggan D, Kalra J, Berkowitz I, Lyss AP. Costanza ME, et al. Clin Cancer Res. 1995 Jul;1(7):699-704. Clin Cancer Res. 1995. PMID: 9816035 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters